12:00 AM
 | 
Feb 19, 2007
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

GeNeuro S.A.

Geneva, Switzerland

Technology: Antibodies against human endogenous retrovirus (HERV) antigens

Disease focus: Multiple sclerosis and other neurodegenerative or neuropsychiatric disorders

Clinical status: Preclinical

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >